Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-28

Clinical Trial Update: Using mTOR Inhibitors in the Prevention of BK Nephropathy [NA]

View source ↗

Summary

A completed clinical trial evaluated the use of mTOR inhibitors to prevent BK virus nephropathy and BK virus viremia in transplant recipients; results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Afinitor (everolimus)
  • Rapamune (sirolimus)

Snippet

Sponsor: Columbia University | Conditions: BK Viremia, BK Nephropathy | NA | Status: COMPLETED | Results posted: 2018-02-28